Quantification of the Impact of Structure Quality on Predicted Binding Free Energy Accuracy
Relative binding free energy (RBFE) calculations have emerged as a powerful tool in drug discovery, capable of achieving experimental-level accuracy. However, the accuracy is compromised by a multitude of factors, including the initial structure modeling. The current study contributes to the quantification of the impact of initial structure modeling on the accuracy across a diverse set of activity cliff pairs. Along with providing a quantitative relation between the resolution of the crystal structure and free energy accuracy, we also demonstrate the incorporation of a secondary solvation tool (SOLVATE) to increase the free energy accuracy, especially when crystal waters are missing. The study also evaluates the reliability of AI-predicted structures in RBFE calculations, showing their effectiveness in predicting RBFE directionality and assigning nominal resolutions to the predicted structures based on free energy accuracy. These findings provide a set of recommendations for the development of more robust RBFE protocols, informing the use of structural data, solvation techniques, and AI-predicted protein models in drug discovery.
Authors
- Vytautas Gapsys (ORCID: https://orcid.org/0000-0002-6761-7780)
- Gary Tresadern (ORCID: https://orcid.org/0000-0002-4801-1644)
- Sudarshan Behera (ORCID: https://orcid.org/0000-0003-1025-0639)
- David F. Hahn (ORCID: https://orcid.org/0000-0003-2830-6880)
- Bert L. de Groot (ORCID: https://orcid.org/0000-0003-3570-3534)
- Carter J. Wilson (ORCID: https://orcid.org/0000-0002-8992-6269)
- Simone Marsili (ORCID: https://orcid.org/0000-0001-6284-6122)
Institutions
- Janssen (Belgium) (BE)
- Max Planck Institute for Multidisciplinary Sciences (DE)
Publication Details
- Journal
- Journal of Chemical Information and Modeling
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1021/acs.jcim.5c00947
- Citations
- 7
- Primary Topic
- Probabilistic and Robust Engineering Design
- Type
- article
- Field-Weighted Citation Impact
- 9.79
Funders
- European Commission
- Janssen Biotech